These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

382 related articles for article (PubMed ID: 27539087)

  • 1. Prognostic role of regenerating gene-I in patients with stage-IV head and neck squamous cell carcinoma.
    Aboshanif M; Kawasaki Y; Omori Y; Suzuki S; Honda K; Motoyama S; Ishikawa K
    Diagn Pathol; 2016 Aug; 11(1):79. PubMed ID: 27539087
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinicopathological and immunohistochemical evaluation of oral and oropharyngeal squamous cell carcinoma in Chilean population.
    Rivera C; González-Arriagada WA; Loyola-Brambilla M; de Almeida OP; Coletta RD; Venegas B
    Int J Clin Exp Pathol; 2014; 7(9):5968-77. PubMed ID: 25337241
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic markers in metastatic cutaneous squamous cell carcinoma of the head and neck.
    Hirshoren N; Danne J; Dixon BJ; Magarey M; Kleid S; Webb A; Tiong A; Corry J; Gyorki D
    Head Neck; 2017 Apr; 39(4):772-778. PubMed ID: 28199044
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic value of circulating biomarker score in advanced-stage head and neck squamous cell carcinoma.
    Park MJ; Roh JL; Kim SB; Choi SH; Nam SY; Kim SY
    Eur J Cancer; 2018 Mar; 92():69-76. PubMed ID: 29428866
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Zinc finger AN1-type containing 4 is a novel marker for predicting metastasis and poor prognosis in oral squamous cell carcinoma.
    Kurihara-Shimomura M; Sasahira T; Nakamura H; Nakashima C; Kuniyasu H; Kirita T
    J Clin Pathol; 2018 May; 71(5):436-441. PubMed ID: 29074611
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association of Human Papillomavirus and p16 Status With Outcomes in the IMCL-9815 Phase III Registration Trial for Patients With Locoregionally Advanced Oropharyngeal Squamous Cell Carcinoma of the Head and Neck Treated With Radiotherapy With or Without Cetuximab.
    Rosenthal DI; Harari PM; Giralt J; Bell D; Raben D; Liu J; Schulten J; Ang KK; Bonner JA
    J Clin Oncol; 2016 Apr; 34(12):1300-8. PubMed ID: 26712222
    [TBL] [Abstract][Full Text] [Related]  

  • 7. FLOT-2 is an independent prognostic marker in oral squamous cell carcinoma.
    Wen Q; Alnemah MM; Luo J; Wang W; Chu S; Chen L; Li J; Xu L; Li M; Zhou J; Fan S
    Int J Clin Exp Pathol; 2015; 8(7):8236-43. PubMed ID: 26339392
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lymph node ratio as a prognostic factor in head and neck cancer patients.
    Chen CC; Lin JC; Chen KW
    Radiat Oncol; 2015 Aug; 10():181. PubMed ID: 26302761
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Low cytoplasmic and nuclear KPNA2 expression in radiotherapy-treated head and neck squamous cell cancer is associated with an adverse outcome.
    Erben PB; Brunner K; Hecht M; Haderlein M; Büttner-Herold M; Agaimy A; Fietkau R; Hartmann A; Distel LV
    Int J Clin Exp Pathol; 2015; 8(12):15814-24. PubMed ID: 26884852
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MiR-21 as prognostic biomarker in head and neck squamous cell carcinoma patients undergoing an organ preservation protocol.
    Arantes LM; Laus AC; Melendez ME; de Carvalho AC; Sorroche BP; De Marchi PR; Evangelista AF; Scapulatempo-Neto C; de Souza Viana L; Carvalho AL
    Oncotarget; 2017 Feb; 8(6):9911-9921. PubMed ID: 28039483
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic biomarkers in patients with human immunodeficiency virus-positive disease with head and neck squamous cell carcinoma.
    Zhang H; Kim S; Chen Z; Nannapaneni S; Chen AY; Moore CE; Sica G; Mosunjac M; Nguyen MLT; D'Souza G; Carey TE; Peterson LA; McHugh JB; Graham M; Komarck CM; Wolf GT; Walline HM; Bellile E; Riddell J; Pai SI; Sidransky D; Westra WH; William WN; Lee JJ; El-Naggar AK; Ferris RL; Seethala R; Grandis JR; Chen ZG; Saba NF; Shin DM;
    Head Neck; 2017 Dec; 39(12):2433-2443. PubMed ID: 28945296
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic significance of basaloid squamous cell carcinoma in head and neck cancer.
    Linton OR; Moore MG; Brigance JS; Gordon CA; Summerlin DJ; McDonald MW
    JAMA Otolaryngol Head Neck Surg; 2013 Dec; 139(12):1306-11. PubMed ID: 24158536
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Levels of TGF-alpha and EGFR protein in head and neck squamous cell carcinoma and patient survival.
    Rubin Grandis J; Melhem MF; Gooding WE; Day R; Holst VA; Wagener MM; Drenning SD; Tweardy DJ
    J Natl Cancer Inst; 1998 Jun; 90(11):824-32. PubMed ID: 9625170
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Independent prognostic role of PD-L1expression in patients with esophageal squamous cell carcinoma.
    Jiang D; Song Q; Wang H; Huang J; Wang H; Hou J; Li X; Xu Y; Sujie A; Zeng H; Tan L; Hou Y
    Oncotarget; 2017 Jan; 8(5):8315-8329. PubMed ID: 28039448
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pretreatment Dysphagia Inventory and videofluorographic swallowing study as prognostic indicators of early survival outcomes in head and neck cancer.
    Yang CJ; Roh JL; Choi KH; Kim MJ; Choi SH; Nam SY; Kim SY
    Cancer; 2015 May; 121(10):1588-98. PubMed ID: 25639759
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comprehensive genomic profiling of head and neck squamous cell carcinoma reveals FGFR1 amplifications and tumour genomic alterations burden as prognostic biomarkers of survival.
    Dubot C; Bernard V; Sablin MP; Vacher S; Chemlali W; Schnitzler A; Pierron G; Ait Rais K; Bessoltane N; Jeannot E; Klijanienko J; Mariani O; Jouffroy T; Calugaru V; Hoffmann C; Lesnik M; Badois N; Berger F; Le Tourneau C; Kamal M; Bieche I
    Eur J Cancer; 2018 Mar; 91():47-55. PubMed ID: 29331751
    [TBL] [Abstract][Full Text] [Related]  

  • 17. HPV Infection and Anemia Status Stratify the Survival of Early T2 Laryngeal Squamous Cell Carcinoma.
    Wang H; Zhang Z; Sun R; Lin H; Gong L; Fang M; Hu WH
    J Voice; 2015 May; 29(3):356-62. PubMed ID: 25484261
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic impact of p53, c-erbB-2 and epidermal growth factor receptor on head and neck carcinoma.
    Parise Junior O; Carvalho LV; Miguel RE; Kowalski LP
    Sao Paulo Med J; 2004 Nov; 122(6):264-8. PubMed ID: 15692721
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Multivariate analysis of potential risk factors for lymph node metastasis in patients with cutaneous squamous cell carcinoma of the head and neck.
    Haisma MS; Plaat BEC; Bijl HP; Roodenburg JLN; Diercks GFH; Romeijn TR; Terra JB
    J Am Acad Dermatol; 2016 Oct; 75(4):722-730. PubMed ID: 27473455
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cisplatin and fluorouracil with or without panitumumab in patients with recurrent or metastatic squamous-cell carcinoma of the head and neck (SPECTRUM): an open-label phase 3 randomised trial.
    Vermorken JB; Stöhlmacher-Williams J; Davidenko I; Licitra L; Winquist E; Villanueva C; Foa P; Rottey S; Skladowski K; Tahara M; Pai VR; Faivre S; Blajman CR; Forastiere AA; Stein BN; Oliner KS; Pan Z; Bach BA;
    Lancet Oncol; 2013 Jul; 14(8):697-710. PubMed ID: 23746666
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.